BetterLife Pharma Inc. Announces Filing of Final Prospectus for US$100 Million Public Offering of Common Shares and Pre-Funded Warrants
FINAL PROSPECTUS ACCESSIBLE ON SEDAR+Vancouver, British Columbia--(. - September 11, 2026) - BetterLife Pharma Inc. CSE:BETR ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, is pleased to announce today that it has filed a final…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.